Issue Date: July 18, 2016
Cipla to build plant in South Africa
The Indian generic drugs company Cipla will spend about $20 million to build a biosimilars plant in Durban, South Africa. Scheduled to come on-line in 2018, the plant, which will mostly produce cancer drugs, will employ about 300 people. Cipla says it hopes that its investment will help make biologic drugs affordable for 20% of the country’s patients, up from just 2% currently.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society